OptiNose
(NASDAQ) OPTN
OptiNose Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$81.86M
Net Income (TTM)
$29.89M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
OPTN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout OptiNose
Industry
Pharmaceuticals
Sector
Health CareEmployees
128
CEO
Ramy A. Mahmoud, MD
Website
www.optinose.comHeadquarters
Yardley, PA 19067, US
OPTN Financials
Key Financial Metrics (TTM)
Gross Margin
91%
Operating Margin
-18%
Net Income Margin
-56%
Return on Equity
45%
Return on Capital
12%
Return on Assets
-20%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$71.00M
Operating Income
$16.32M
EBITDA
$1.20M
Operating Cash Flow
$44.89M
Capital Expenditure
$72.00K
Free Cash Flow
$44.75M
Cash & ST Invst.
$84.48M
Total Debt
$128.96M
OptiNose Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$18.51M
+24.4%
Gross Profit
$16.76M
+23.5%
Gross Margin
90.55%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
127
N/A
Net Income
$22.42M
-59.4%
EBITDA
$7.53M
+16.5%
Quarterly Fundamentals
Net Cash
$54.27M
+31.9%
Accounts Receivable
$23.14M
+62.7%
Inventory
$11.30M
+9.5%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$127.20M
+17445.5%
Return on Assets
-19.83%
N/A
Return on Invested Capital
12.03%
N/A
Free Cash Flow
$11.55M
+47.6%
Operating Cash Flow
$11.55M
+47.6%